Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.820
-0.010 (-0.21%)
Sep 28, 2026, 1:37 PM EDT - Market open
Cingulate Market Cap
Cingulate has a market cap or net worth of $70.09 million as of September 28, 2026. Its market cap has increased by 228.16% in one year.
Market Cap
70.09M
Enterprise Value
47.98M
1-Year Change
228.16%
Ranking
Category
Stock Price
$4.82
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $70.09M, an increase of 9.03%. That is a compound annual growth rate of 1.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 70.09M | 139.01% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioStem Technologies | 73.90M |
| MAIA Biotechnology | 72.99M |
| Aldeyra Therapeutics | 72.69M |
| OKYO Pharma | 72.42M |
| Spero Therapeutics | 71.63M |
| Kalaris Therapeutics | 69.51M |
| Champions Oncology | 68.20M |
| Connect Biopharma Holdings | 68.01M |